OUR VISION is to be the world’s leader in nanosensor-based, point-of-care diagnostics for a wide variety of diseases including Covid-19, Traumatic Brain Injury (TBI), Sepsis and Stroke.
OUR VALUES include holding ourselves to the highest quality standards, driving to be the best in the industry, both individually and collectively, and having the highest levels of integrity and ethical behavior.
President & CEO
James A. Wylie
Chief Scientific Officer
Vice President of North American Sales
NanoDx™ is always searching for new opportunities. Contact us today with any questions or inquiries.